Take the pledge to vote

For a better tommorow#AajSawaroApnaKal
  • I agree to receive emails from News18

  • I promise to vote in this year's elections no matter what the odds are.
  • Please check above checkbox.

    SUBMIT

Thank you for
taking the pledge

Vote responsibly as each vote counts
and makes a diffrence

Disclaimer:

Issued in public interest by HDFC Life. HDFC Life Insurance Company Limited (Formerly HDFC Standard Life Insurance Company Limited) (“HDFC Life”). CIN: L65110MH2000PLC128245, IRDAI Reg. No. 101 . The name/letters "HDFC" in the name/logo of the company belongs to Housing Development Finance Corporation Limited ("HDFC Limited") and is used by HDFC Life under an agreement entered into with HDFC Limited. ARN EU/04/19/13618
LIVE TV DownloadNews18 App
News18 English

52mn Children Lived With Viral Hepatitis Worldwide in 2016

In 2016, an estimated 325 million people were living with viral hepatitis worldwide.

IANS

Updated:November 3, 2017, 6:11 PM IST
facebookTwitterskypewhatsapp
52mn Children Lived With Viral Hepatitis Worldwide in 2016
Representative Image (Photo courtesy: AFP Relaxnews/ Pressmaster/ shutterstock.com)

Fifty two million children lived with viral hepatitis worldwide in 2016, while 2.1 million suffered from HIV/AIDS, a new study has revealed.

In 2016, an estimated 325 million people were living with viral hepatitis worldwide.

Of these, four million were children living with hepatitis C (under 19 years) and 48 million (under 18 years) were children living with hepatitis B. Both viruses can lead to liver disease, liver cancer and death, the findings presented at the 2017 World Hepatitis Summit in Brazil, showed.

"Children are suffering a huge burden of viral hepatitis worldwide and the public health implications of this are enormous," said Raquel Peck, CEO of the World Hepatitis Alliance -- London-based not-for-profit.

Twenty one countries are responsible for around 80 per cent of these pediatric hepatitis C infections, with the highest prevalence rates generally found in developing countries, noted Manal El-Sayed, professor in Egypt's Shams University.

The main causes of hepatitis C in children is mother to child transmission. However, neither pregnant women nor young children with this cancer-causing illness can be treated with the highly effective direct-acting antiviral (DAA) medications, as health experts are yet to recommend the vaccine in children.

Further, the study showed that compared to hepatitis C, new hepatitis B infections among children are declining -- from approximately 4.7 per cent prevalence in the pre-vaccination era of the early 1980s to 1.3 per cent.

This is due to scaled-up efforts to prevent mother-to-child transmission and global coverage with the three doses of hepatitis B vaccine.

Currently, 84 per cent of countries offer hepatitis B vaccinations. However, coverage with the initial birth dose vaccination needed to provide protection to newborns is still low at 39 per cent, the researchers added.

Get the best of News18 delivered to your inbox - subscribe to News18 Daybreak. Follow News18.com on Twitter, Instagram, Facebook, Telegram, TikTok and on YouTube, and stay in the know with what's happening in the world around you – in real time.

| Edited by: Manila Venugopal
Read full article
Next Story
Next Story

Also Watch

facebookTwitterskypewhatsapp

Live TV

Countdown To Elections Results
To Assembly Elections 2018 Results